Skip to main content

MoneyWorks4Me

Indoco Remedies informs about press release

14 Sep 2020 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indoco Remedies has informed that it has enclosed a Press Release on 14th September 2020 titled ‘Indoco receives USFDA approval for Apixaban Tablets’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1900.20
Dr. Reddys Labs. 1388.10
Cipla 1414.85
Lupin 1987.85
Zydus Lifesciences 1197.10
View more..